|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 222 for Dpp4

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.043s

Categories

Category: Publication
Type Details Score
Publication
First Author: Baumeier C
Year: 2017
Journal: Diabetes
Title: Hepatic DPP4 DNA Methylation Associates With Fatty Liver.
Volume: 66
Issue: 1
Pages: 25-35
Publication
First Author: Ghorpade DS
Year: 2018
Journal: Nature
Title: Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Volume: 555
Issue: 7698
Pages: 673-677
Publication
First Author: Baumeier C
Year: 2017
Journal: Mol Metab
Title: Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.
Volume: 6
Issue: 10
Pages: 1254-1263
Publication
First Author: Patarrão RS
Year: 2022
Journal: Diabetologia
Title: Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.
Volume: 65
Issue: 5
Pages: 861-871
Publication
First Author: Fadzeyeva E
Year: 2023
Journal: iScience
Title: Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress.
Volume: 26
Issue: 5
Pages: 106748
Publication
First Author: Zhong J
Year: 2013
Journal: Diabetes
Title: A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Volume: 62
Issue: 1
Pages: 149-57
Publication
First Author: Li K
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
Volume: 114
Issue: 15
Pages: E3119-E3128
Publication
First Author: Sueyoshi R
Year: 2014
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Volume: 307
Issue: 4
Pages: G410-9
Publication
First Author: Romacho T
Year: 2020
Journal: Am J Physiol Endocrinol Metab
Title: DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Volume: 318
Issue: 5
Pages: E590-E599
Publication
First Author: Baggio LL
Year: 2020
Journal: Nat Commun
Title: Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
Volume: 11
Issue: 1
Pages: 3766
Publication
First Author: Varin EM
Year: 2019
Journal: Cell Metab
Title: Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Volume: 29
Issue: 2
Pages: 320-334.e5
Publication
First Author: Hollande C
Year: 2019
Journal: Nat Immunol
Title: Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
Volume: 20
Issue: 3
Pages: 257-264
Publication
First Author: O'Leary HA
Year: 2017
Journal: Leukemia
Title: DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.
Volume: 31
Issue: 11
Pages: 2468-2478
Publication  
First Author: Hui Y
Year: 2023
Journal: Metabolism
Title: Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization.
Volume: 138
Pages: 155340
Publication  
First Author: Munster VJ
Year: 2017
Journal: NPJ Vaccines
Title: Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model.
Volume: 2
Pages: 28
Publication
First Author: Dingenouts CKE
Year: 2017
Journal: PLoS One
Title: Inhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction.
Volume: 12
Issue: 12
Pages: e0189805
Publication
First Author: Ye Y
Year: 2017
Journal: Cardiovasc Drugs Ther
Title: SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
Volume: 31
Issue: 2
Pages: 119-132
Publication  
First Author: Iwata-Yoshikawa N
Year: 2019
Journal: J Virol
Title: Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
Volume: 93
Issue: 6
Publication  
First Author: Tai W
Year: 2016
Journal: Virology
Title: A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Volume: 499
Pages: 375-382
Publication  
First Author: Leist SR
Year: 2020
Journal: Methods Mol Biol
Title: Genetically Engineering a Susceptible Mouse Model for MERS-CoV-Induced Acute Respiratory Distress Syndrome.
Volume: 2099
Pages: 137-159
Publication  
First Author: Gutiérrez-Álvarez J
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
Volume: 118
Issue: 43
Publication
First Author: Wang C
Year: 2023
Journal: Cell Rep
Title: Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells.
Volume: 42
Issue: 2
Pages: 112105
Publication
First Author: Jia W
Year: 2019
Journal: Emerg Microbes Infect
Title: Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
Volume: 8
Issue: 1
Pages: 760-772
Publication  
First Author: Li K
Year: 2020
Journal: mBio
Title: Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
Volume: 11
Issue: 2
Publication  
First Author: Varin EM
Year: 2020
Journal: JCI Insight
Title: Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.
Volume: 5
Issue: 16
Publication
First Author: Mulvihill EE
Year: 2016
Journal: Diabetes
Title: Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Volume: 65
Issue: 3
Pages: 742-54
Publication
First Author: Bernard AM
Year: 1994
Journal: Biochemistry
Title: Structure of the mouse dipeptidyl peptidase IV (CD26) gene.
Volume: 33
Issue: 50
Pages: 15204-14
Publication  
First Author: Coleman CM
Year: 2017
Journal: J Virol
Title: CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.
Volume: 91
Issue: 1
Publication
First Author: Soare A
Year: 2020
Journal: Arthritis Rheumatol
Title: Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Volume: 72
Issue: 1
Pages: 137-149
Publication
First Author: Yuan L
Year: 2020
Journal: Emerg Microbes Infect
Title: Animal models for emerging coronavirus: progress and new insights.
Volume: 9
Issue: 1
Pages: 949-961
Publication
First Author: Barreira da Silva R
Year: 2015
Journal: Nat Immunol
Title: Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
Volume: 16
Issue: 8
Pages: 850-8
Publication
First Author: Mulvihill EE
Year: 2017
Journal: Cell Metab
Title: Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Volume: 25
Issue: 1
Pages: 152-165
Publication
First Author: Kyle KA
Year: 2011
Journal: Endocrinology
Title: Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice.
Volume: 152
Issue: 2
Pages: 457-67
Publication
First Author: Jussila AR
Year: 2022
Journal: J Invest Dermatol
Title: Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4.
Volume: 142
Issue: 6
Pages: 1597-1606.e9
Publication
First Author: Earnest JT
Year: 2017
Journal: PLoS Pathog
Title: The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
Volume: 13
Issue: 7
Pages: e1006546
Publication  
First Author: Piao L
Year: 2017
Journal: J Am Heart Assoc
Title: Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
Volume: 6
Issue: 10
Publication
First Author: Nazarian A
Year: 2014
Journal: Mol Cell Proteomics
Title: Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Volume: 13
Issue: 11
Pages: 3082-96
Publication
First Author: Strathmann EA
Year: 2018
Journal: PLoS One
Title: Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.
Volume: 13
Issue: 9
Pages: e0203398
Publication
First Author: Singh A
Year: 2020
Journal: Virol Sin
Title: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
Volume: 35
Issue: 3
Pages: 290-304
Publication
First Author: Marguet D
Year: 1992
Journal: J Biol Chem
Title: cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases.
Volume: 267
Issue: 4
Pages: 2200-8
Publication  
First Author: Menachery VD
Year: 2017
Journal: mBio
Title: MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis.
Volume: 8
Issue: 4
Publication
First Author: Pascal KE
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.
Volume: 112
Issue: 28
Pages: 8738-43
Publication  
First Author: Kulcsar KA
Year: 2019
Journal: JCI Insight
Title: Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.
Volume: 4
Issue: 20
Publication  
First Author: Gutierrez-Alvarez J
Year: 2021
Journal: J Virol
Title: Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
Volume: 95
Issue: 3
Publication
First Author: Wong L-YR
Year: 2023
Journal: mBio
Title: Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice.
Volume: 14
Issue: 6
Pages: e0247623
Publication  
First Author: Verma AK
Year: 2022
Journal: JCI Insight
Title: SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways.
Volume: 7
Issue: 24
Publication  
First Author: Cockrell AS
Year: 2016
Journal: Nat Microbiol
Title: A mouse model for MERS coronavirus-induced acute respiratory distress syndrome.
Volume: 2
Pages: 16226
Publication  
First Author: Sheahan TP
Year: 2020
Journal: Sci Transl Med
Title: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Volume: 12
Issue: 541
Publication  
First Author: Douglas MG
Year: 2018
Journal: Virology
Title: Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease.
Volume: 517
Pages: 98-107
Publication
First Author: Leist SR
Year: 2019
Journal: PLoS One
Title: Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis.
Volume: 14
Issue: 7
Pages: e0220126
Publication
First Author: Marguet D
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.
Volume: 97
Issue: 12
Pages: 6874-9
Publication
First Author: Takasawa W
Year: 2010
Journal: Biochem Biophys Res Commun
Title: Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines.
Volume: 401
Issue: 1
Pages: 7-12
Publication
First Author: El Yacoubi M
Year: 2006
Journal: Behav Brain Res
Title: Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity.
Volume: 171
Issue: 2
Pages: 279-85
Publication
First Author: Sauvé M
Year: 2010
Journal: Diabetes
Title: Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Volume: 59
Issue: 4
Pages: 1063-73
Publication
First Author: Detel D
Year: 2012
Journal: Exp Physiol
Title: Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV.
Volume: 97
Issue: 4
Pages: 486-96
Publication
First Author: Kidd S
Year: 2011
Journal: Exp Hematol
Title: In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice.
Volume: 39
Issue: 5
Pages: 580-590.e1
Publication
First Author: Zaruba MM
Year: 2009
Journal: Cell Stem Cell
Title: Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.
Volume: 4
Issue: 4
Pages: 313-23
Publication
First Author: Yan S
Year: 2003
Journal: Eur J Immunol
Title: Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.
Volume: 33
Issue: 6
Pages: 1519-27
Publication
First Author: Duarte N
Year: 2018
Journal: Hepatol Commun
Title: Dipeptidyl Peptidase-4 Is a Pro-Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells.
Volume: 2
Issue: 9
Pages: 1080-1094
Publication
First Author: Yan S
Year: 2012
Journal: Eur J Immunol
Title: Enhanced ovalbumin-induced airway inflammation in CD26-/- mice.
Volume: 42
Issue: 2
Pages: 533-40
Publication
First Author: Christopherson KW 2nd
Year: 2004
Journal: Science
Title: Modulation of hematopoietic stem cell homing and engraftment by CD26.
Volume: 305
Issue: 5686
Pages: 1000-3
Publication
First Author: Guieu R
Year: 2006
Journal: Behav Brain Res
Title: CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
Volume: 166
Issue: 2
Pages: 230-5
Publication
First Author: Tinoco AD
Year: 2011
Journal: Biochemistry
Title: A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones.
Volume: 50
Issue: 12
Pages: 2213-22
Publication
First Author: Conarello SL
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance.
Volume: 100
Issue: 11
Pages: 6825-30
Publication
First Author: Jang JH
Year: 2015
Journal: Clin Exp Metastasis
Title: Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
Volume: 32
Issue: 7
Pages: 677-87
Publication
First Author: Preller V
Year: 2007
Journal: J Immunol
Title: TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
Volume: 178
Issue: 7
Pages: 4632-40
Publication
First Author: Brunaugh AD
Year: 2021
Journal: PLoS One
Title: Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae.
Volume: 16
Issue: 2
Pages: e0246803
Publication
First Author: Arwert EN
Year: 2012
Journal: Oncogene
Title: Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation.
Volume: 31
Issue: 8
Pages: 992-1000
Publication
First Author: David F
Year: 1993
Journal: J Biol Chem
Title: Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases.
Volume: 268
Issue: 23
Pages: 17247-52
Publication
First Author: Mentzel S
Year: 1996
Journal: J Histochem Cytochem
Title: Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice.
Volume: 44
Issue: 5
Pages: 445-61
Publication
First Author: Gliddon DR
Year: 2002
Journal: Eur J Immunol
Title: CD26 is expressed on a restricted subpopulation of dendritic cells in vivo.
Volume: 32
Issue: 5
Pages: 1472-81
Publication
First Author: Engel M
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.
Volume: 100
Issue: 9
Pages: 5063-8
Publication
First Author: Sakurada C
Year: 2003
Journal: Biochem Pharmacol
Title: Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study.
Volume: 66
Issue: 4
Pages: 653-61
Publication
First Author: Barrett AJ
Year: 1996
Journal: Eur J Biochem
Title: Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme nomenclature. Recommendations 1992. Supplement 3: corrections and additions (1995).
Volume: 237
Issue: 1
Pages: 1-5
Publication
First Author: Min HS
Year: 2014
Journal: Lab Invest
Title: Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction.
Volume: 94
Issue: 6
Pages: 598-607
Publication  
First Author: Du L
Year: 2016
Journal: Nat Commun
Title: Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.
Volume: 7
Pages: 13473
Publication
First Author: Liu L
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets.
Volume: 453
Issue: 3
Pages: 398-404
Publication  
First Author: Raha AA
Year: 2020
Journal: Biosci Rep
Title: Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.
Volume: 40
Issue: 12
Publication
First Author: Johansen MD
Year: 2020
Journal: Mucosal Immunol
Title: Animal and translational models of SARS-CoV-2 infection and COVID-19.
Volume: 13
Issue: 6
Pages: 877-891
Publication
First Author: Pilz A
Year: 1993
Journal: Mouse Genome
Title: Genetic mapping of the dipeptidylpeptidase IV gene on mouse Chromosome 2
Volume: 91
Issue: 4
Pages: 882-84
Publication
First Author: Niedermeyer J
Year: 2000
Journal: Mol Cell Biol
Title: Targeted disruption of mouse fibroblast activation protein.
Volume: 20
Issue: 3
Pages: 1089-94
Publication
First Author: Barreira da Silva R
Year: 2022
Journal: Nat Immunol
Title: Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity.
Volume: 23
Issue: 4
Pages: 568-580
Publication  
First Author: Zheng J
Year: 2021
Journal: J Clin Invest
Title: Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.
Volume: 131
Issue: 11
Publication
First Author: Sheahan TP
Year: 2020
Journal: Nat Commun
Title: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Volume: 11
Issue: 1
Pages: 222
Publication
First Author: Jang JH
Year: 2019
Journal: Carcinogenesis
Title: The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Volume: 40
Issue: 2
Pages: 324-334
Publication
First Author: Singh P
Year: 2017
Journal: J Clin Invest
Title: Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells.
Volume: 127
Issue: 12
Pages: 4527-4540
Publication
First Author: Sternkopf M
Year: 2020
Journal: Arterioscler Thromb Vasc Biol
Title: Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
Volume: 40
Issue: 3
Pages: e65-e77
Publication
First Author: Christopherson KW
Year: 2003
Journal: Exp Hematol
Title: CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice.
Volume: 31
Issue: 11
Pages: 1126-34
Publication
First Author: Jessen L
Year: 2012
Journal: Endocrinology
Title: Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4.
Volume: 153
Issue: 12
Pages: 5735-45
Publication
First Author: Kawakubo M
Year: 2020
Journal: Sci Rep
Title: Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Volume: 10
Issue: 1
Pages: 983
Publication
First Author: Hasegawa Y
Year: 2017
Journal: Cardiovasc Diabetol
Title: DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho-/- mice.
Volume: 16
Issue: 1
Pages: 154
Publication
First Author: Powell DR
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: Improved glycemic control in mice lacking Sglt1 and Sglt2.
Volume: 304
Issue: 2
Pages: E117-30
Publication
First Author: Ambrosi TH
Year: 2017
Journal: Cell Stem Cell
Title: Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration.
Volume: 20
Issue: 6
Pages: 771-784.e6
Publication
First Author: Buljevic S
Year: 2018
Journal: J Cell Biochem
Title: The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
Volume: 119
Issue: 8
Pages: 6743-6755
Publication
First Author: Mizutani S
Year: 2006
Journal: Mamm Genome
Title: Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse.
Volume: 17
Issue: 5
Pages: 375-84
Publication
First Author: Willard JR
Year: 2017
Journal: Diabetologia
Title: Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.
Volume: 60
Issue: 4
Pages: 701-708
Publication
First Author: Zhang Y
Year: 2017
Journal: Biomed Hub
Title: The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Reduces Aortic Damage from Hypercholesterolaemia in Apolipoprotein E-Deficient Mice.
Volume: 2
Issue: 2
Pages: 1-9
Publication
First Author: Sato K
Year: 2012
Journal: Endocrinology
Title: Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
Volume: 153
Issue: 3
Pages: 1093-102
Publication
First Author: Channappanavar R
Year: 2019
Journal: J Clin Invest
Title: IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes.
Volume: 129
Issue: 9
Pages: 3625-3639
Publication      
First Author: Smyth LCD
Year: 2024
Journal: Nature
Title: Identification of direct connections between the dura and the brain.